ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Aortic Valve

October 10, 2023
In the appropriate patient, the Ross procedure provides the best survival curves, hemodynamics, and a normal lifestyle in patients with aortic valve pathology.
October 6, 2023
As a part of the 2023 Australian Thoracic Aortic Symposium, Dr. Edward Chen presented on his methods for valve repair in patients with a bicuspid aortic valve.
October 4, 2023
A newly published review by Dr. David on aortic valve sparing operations
September 28, 2023
The optimal timing for AVR in young adults can be hard to predict with the lack of evidence-based guidelines. One third of a total of 172 patients recruited from a single tertiary cardiac center between 2005-2019 underwent surgery before meeting guideline indications, but they were more likely to normalize their LV postoperatively.
September 28, 2023
Unicuspid aortic valve requires intervention in early life and the ideal treatment is unknown. This study examined 345 patients divided into two groups: 167 undergoing valve repair and 91 undergoing a Ross procedure.
September 22, 2023
Dr. Markus Kasel, an interventional cardiologist at University Hospital of Zurich, discusses his techniques and standards for lifetime management of aortic stenosis in a wide range of patients.
September 8, 2023
This paper explores the application of a novel aortic valve visualization and pressurization device to inspect the valve under physiological conditions following aortic repair.
August 30, 2023
While much research is ongoing regarding the safety of transcatheter aortic valve replacement (TAVR) compared to surgical aortic valve replacement (SAVR) after prior coronary artery bypass (CABG), there is limited data on morbidity outcomes and discharge locations among these two procedures.
August 16, 2023
Recently, NICE released guidance from the British regulatory body limiting the Ozaki operation to research until further review, which is scheduled in three calendar years. The overarching concern appears to be the durability of the autoprosthesis. NICE guidelines have the strongest influence in healthcare in the United Kingdom and often abroad.
July 27, 2023
In forty-eight consecutive patients undergoing explants of transcatheter aortic valve replacement (TAVR) at a single center between 2011 and 2021, at a median of 2.3 years after TAVR, the most common indications for surgery were nonstructural valve dysfunction (patient-prosthesis mismatch or paravalvular leak) in 35 percent, structural valve deterior

Pages